載入...
Stachydrine prevents LPS‐induced bone loss by inhibiting osteoclastogenesis via NF‐κB and Akt signalling
Osteoclast overactivation‐induced imbalance in bone remodelling leads to pathological bone destruction, which is a characteristic of many osteolytic diseases such as rheumatoid arthritis, osteoporosis, periprosthetic osteolysis and periodontitis. Natural compounds that suppress osteoclast formation...
Na minha lista:
| 發表在: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787569/ https://ncbi.nlm.nih.gov/pubmed/31328430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14551 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|